BRAF and cancer: The other way to achieve ultimate suppression of cancer growth detouring the Raf dimer dilemma is to block both Raf kinases (B-Raf, C-Raf, and mutant B-Raf) and receptor tyrosine kinases linked to activation of MAPKs, such as VEGFR-2.